PharmaCielo Ltd. (TSXV:PCLO)
Canada
· Delayed Price · Currency is CAD 0.0550
-0.0100 (-15.38%)
Apr 2, 2025, 3:48 PM EST
PharmaCielo Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -9.14 | -16.3 | -14.52 | -26.63 | -43.76 | Upgrade
|
| Depreciation & Amortization | 0.14 | 0.36 | 0.43 | 0.26 | 1.04 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | -0.04 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.91 | 4.23 | 1.27 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.03 | 0.14 | 0.43 | -0.41 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 0.64 | 0.47 | 0.72 | Upgrade
|
| Stock-Based Compensation | 1.04 | 1.54 | 2.21 | 6.82 | 6.48 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.02 | 0 | 0.2 | 2.52 | Upgrade
|
| Other Operating Activities | 4.29 | 2.8 | 1.78 | 5.95 | 7.53 | Upgrade
|
| Change in Accounts Receivable | -0.13 | 0.42 | -0.4 | 0.13 | -1.99 | Upgrade
|
| Change in Inventory | 0.39 | 0.75 | -1.01 | -3.42 | -4.72 | Upgrade
|
| Change in Accounts Payable | 0.28 | 0.67 | -0.35 | -4.47 | 9.78 | Upgrade
|
| Change in Other Net Operating Assets | 0.26 | 0.38 | -0.03 | 0.19 | 0.24 | Upgrade
|
| Operating Cash Flow | -1.97 | -5.15 | -9.88 | -20.07 | -22.56 | Upgrade
|
| Capital Expenditures | - | -0.02 | -0.52 | -1.14 | -5.43 | Upgrade
|
| Investment in Securities | - | 0.18 | -0.2 | 0.23 | -0.14 | Upgrade
|
| Other Investing Activities | 0.04 | 0.23 | 0.17 | -0.75 | - | Upgrade
|
| Investing Cash Flow | 0.04 | 0.39 | -0.56 | -1.66 | -5.57 | Upgrade
|
| Long-Term Debt Issued | 0.99 | 5.45 | 5.8 | 5 | 3.15 | Upgrade
|
| Long-Term Debt Repaid | -0.52 | -0.82 | -0.62 | -0.39 | -0.26 | Upgrade
|
| Total Debt Repaid | -0.52 | -0.82 | -0.62 | -0.39 | -0.26 | Upgrade
|
| Net Debt Issued (Repaid) | 0.47 | 4.63 | 5.17 | 4.61 | 2.89 | Upgrade
|
| Issuance of Common Stock | 1.55 | - | 0.08 | 14.88 | 20.39 | Upgrade
|
| Other Financing Activities | - | - | 0.04 | -1.28 | 0.04 | Upgrade
|
| Financing Cash Flow | 2.02 | 4.63 | 5.3 | 18.21 | 23.32 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | 0.02 | -0.03 | - | - | Upgrade
|
| Net Cash Flow | 0.09 | -0.11 | -5.17 | -3.52 | -4.81 | Upgrade
|
| Free Cash Flow | -1.97 | -5.17 | -10.4 | -21.21 | -28 | Upgrade
|
| Free Cash Flow Margin | -56.59% | -335.01% | -195.86% | -1090.55% | -1054.97% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.07 | -0.15 | -0.25 | Upgrade
|
| Cash Interest Paid | 1.23 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -2.45 | -4.45 | -6.63 | -14.47 | -12.43 | Upgrade
|
| Unlevered Free Cash Flow | -1.03 | -4.45 | -6.63 | -14.35 | -12.43 | Upgrade
|
| Change in Net Working Capital | -0.7 | 0.05 | 1.83 | 4.63 | -11.64 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.